Immunoprecipitation

Global Cell Separation Market Size, Share & Trends Analysis Report 2023-2030: Centrifugation Reigns Supreme, Wide Range of Options Elevates Cell Separation Market Share - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 12, 2023

The global cell separation market size is expected to reach USD 9.05 billion by 2030, registering a CAGR of 9.82%.

Key Points: 
  • The global cell separation market size is expected to reach USD 9.05 billion by 2030, registering a CAGR of 9.82%.
  • The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth.
  • Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production.
  • These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.

Mammalian Polyclonal IgG Antibody Global Market Report 2023: Growing Prevalence of Standard Laboratory Tests Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 16, 2023

The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
  • The mammalian polyclonal IgG antibody market size is estimated to be USD 1,347.4 million in 2022 and is expected to witness a CAGR of 5.28% during the forecast period 2023-2033.
  • Furthermore, growing prevalence of standard laboratory tests, government investment, acceleration in institutional and academic research, and affordability of supporting equipment and technology are other factors supporting the market growth.
  • Growing prevalence of standard laboratory tests such as microarray assays, western blot analysis, immunohistochemical, and cell imaging is predicted to propel the mammalian polyclonal IgG antibody market growth during the forecast period.

Eclipsebio Announces Publication of New Method to Optimize and Scale the Detection of RNA-Binding Protein Sites to Accelerate the Understanding of RNA Regulation

Retrieved on: 
Tuesday, January 17, 2023

The study, published in Nature Methods , was led by Eclipsebio’s Associate Director of Research Daniel Lorenz, Ph.D., and co-founder Gene Yeo, Ph.D.

Key Points: 
  • The study, published in Nature Methods , was led by Eclipsebio’s Associate Director of Research Daniel Lorenz, Ph.D., and co-founder Gene Yeo, Ph.D.
  • Enhanced cross-linking immunoprecipitation followed by high-throughput sequencing, or eCLIP , is a powerful technique to uncover RNA sequences where RNA-binding proteins (RBPs) bind, known as RBP interactomes.
  • RBPs regulate RNA molecules, controlling the function and quantity of proteins expressed in a cell.
  • We look forward to supporting important RBP research with our current and future eCLIP products that will include the ABC technology.”

Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing

Retrieved on: 
Monday, January 9, 2023

This partnership seeks to co-develop protein enrichment kits to enable deep interrogation of proteins of interest and their variants (proteoforms) through protein sequencing.

Key Points: 
  • This partnership seeks to co-develop protein enrichment kits to enable deep interrogation of proteins of interest and their variants (proteoforms) through protein sequencing.
  • The co-developed products will include immunoprecipitation kits that fit into existing research workflows to conveniently enrich target proteins prior to amino acid mutation or post-translational modification (PTM) analysis with Quantum-Si’s PlatinumTM protein sequencing platform.
  • "This partnership brings together unique capabilities from Quantium-Si and Aviva Systems Biology that will accelerate new discoveries in protein research," said Kevin Harvey, President of Aviva.
  • "Speeding up new discoveries is a shared goal at Quantum-Si and Aviva Systems Biology, and we are excited to partner with Quantum-Si to drive proteomics research forward."

Protein Purification and Isolation Global Market Report 2022: Rise in the Need for Identifying New Ligands Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, October 24, 2022

The "Protein Purification and Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Protein Purification and Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global protein purification and isolation market size reached US$ 7.5 Billion in 2021.
  • Protein purification and isolation refer to a series of processes undertaken for isolating a type of protein from a complex mixture of cells, organisms, or tissues.
  • Protein Purification and Isolation Market Trends:
    The burgeoning pharmaceutical industry across the globe represents one of the primary factors strengthening the growth of the market.

ANGUS LAUNCHES COMMERCIAL PRODUCTION OF HEPES BUFFER

Retrieved on: 
Tuesday, October 25, 2022

BUFFALO GROVE, Ill., Oct. 25, 2022 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial launch of HEPES buffer produced at its Sterlington, Louisiana facility.

Key Points: 
  • BUFFALO GROVE, Ill., Oct. 25, 2022 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial launch of HEPES buffer produced at its Sterlington, Louisiana facility.
  • HEPES is multi-purpose biological buffer often used to maintain a physiological pH which provides the ideal environment for cells to grow and thrive.
  • HEPES buffer (INCI: Hydroxyethylpiperazine Ethane Sulfonic Acid) can also be used in combination with other ingredients to support the quality and performance of skincare and cosmetics products.
  • "The expansion into commercial production of HEPES is a natural fit with our strategy to become the world's most transparent and dependable manufacturer of essential upstream and downstream bioprocessing chemistries," said ANGUS President and CEO David Neuberger.

Trilogene Seeds Accelerates Cannabis Biotech Research at SIU's Saluki Innovation Lab

Retrieved on: 
Wednesday, October 19, 2022

CARBONDALE, Ill., Oct. 19, 2022 /PRNewswire/ -- Trilogene Seeds announces advanced hemp research initiative at Saluki Innovation Lab at Southern Illinois University Research Park.

Key Points: 
  • CARBONDALE, Ill., Oct. 19, 2022 /PRNewswire/ -- Trilogene Seeds announces advanced hemp research initiative at Saluki Innovation Lab at Southern Illinois University Research Park.
  • The team plans to leverage genomic tools and agricultural biotechnology with the aim of developing and breeding cannabis and hemp genetics of the future.
  • "We are committed to accelerating the development of this complex plant and will continue to push research forward at our new genomics lab in Illinois.
  • This opportunity at SIU's innovation center will allow us to lean on university expertise and infrastructure to accelerate our genetic development projects," says Matt Haddad, CEO/Founder of Trilogene Seeds.

Research Antibodies & Reagents Market - Global Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 22, 2022

The "Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western Blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End-user (Pharma, Biotech, CROs), and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western Blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End-user (Pharma, Biotech, CROs), and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7%
    The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility, and increasing R&D expenditure in the life sciences industry.
  • It is expected that the global research antibodies and reagents market will witness significant growth in the coming years.
  • On the basis of product, the reagents segment holds the highest market share during the forecast period
    On the basis of product, the research antibodies and reagents market are segmented into reagent and antibodies.

Shimadzu Launches Blood-Based Amyloid Mass Spectrometry Service in North America for Supporting Alzheimer's Disease Drug Discovery and Development

Retrieved on: 
Friday, July 8, 2022

COLUMBIA, Md., July 8, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals. This simple, research-use-only blood-based analysis method enables reliable characterization of amyloid pathology in the brain with an easy-to-acquire blood sample to assist in the evaluation and development of new pharmaceutical treatments for Alzheimer's disease.

Key Points: 
  • Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals.
  • COLUMBIA, Md., July 8, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS) Service for the early screening of amyloid-positive individuals.
  • Experts from Shimadzu will present information about the Amyloid Mass Spectrometry (MS) Service at booth 206 at the Alzheimer's Association International Conference from July 31August 4, 2022, in San Diego, California.
  • About Shimadzu Scientific Instruments Inc.
    Shimadzu Scientific Instruments (SSI) is the North American subsidiary of Shimadzu Corporation's Analytical and Measuring Division.

Research Antibodies and Reagents Global Market Research Report 2022 Featuring Major Players - Abcam, Merck, Cell Signaling Technology, GE Healthcare, Thermo Fisher Scientific - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022

The "Research Antibodies and Reagents Global Market Report 2022: By Technology, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Antibodies and Reagents Global Market Report 2022: By Technology, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.
  • Research Antibodies and Reagents Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global research antibodies and reagents market.
  • This report focuses on research antibodies and reagents market which is experiencing strong growth.
  • It compares the research antibodies and reagents market with other segments of the research antibodies and reagents market by size and growth, historic and forecast.